Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

International Institute Of Cancer Immunology Inc patents


Recent patent applications related to International Institute Of Cancer Immunology Inc. International Institute Of Cancer Immunology Inc is listed as an Agent/Assignee. Note: International Institute Of Cancer Immunology Inc may have other listings under different names/spellings. We're not affiliated with International Institute Of Cancer Immunology Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | International Institute Of Cancer Immunology Inc-related inventors


Hla-dr-binding antigen peptide derived from wt1

The present invention provides a wt1-derived hla-drb1*0405-binding antigen peptide, a polynucleotide encoding said peptide, a helper t cell inducer comprising said peptide or polynucleotide, and the like. It is related to a partial peptide consisting of 10-25 contiguous amino acids in the amino acid sequence of human wt1 shown in seq id no: 1, which binds to hla-drb1*0405 and induces helper t cells, a polynucleotide encoding said peptide, or a helper t cell inducer comprising said peptide or polynucleotide.. ... International Institute Of Cancer Immunology Inc

Cancer antigen helper peptide

The present invention relates to a wt1 peptide which has an amino acid sequence consisting of contiguous amino acids derived from a wt1 protein and induces wt1-specific helper t cells by binding to an mhc class ii molecule, a pharmaceutical composition comprising them and the like.. . ... International Institute Of Cancer Immunology Inc

Combination use of wt1 antigen peptide and immunomodulator

The invention relates to a combination use of a wt1 antigen peptide or a pharmaceutically acceptable salt thereof and an immunomodulator for treating or preventing cancer.. . ... International Institute Of Cancer Immunology Inc

Hla-a* 1101-restricted wt1 peptide and pharmaceutical composition comprising the same

An hla-a*1101-restricted wt1 peptide, specifically, a peptide comprising an amino acid sequence consisting of 9 contiguous amino acids from a wt1 protein, wherein the peptide has an ability to bind to an hla-a*1101 molecule, and has an ability to induce a ctl is described. A peptide dimer having an ability to bind to an hla-a*1101 molecule and having an ability to induce a ctl, in which two peptide monomers each comprising an amino acid sequence consisting of 9 contiguous amino acids from a wt1 protein and comprising at least one cysteine residue are bound to each other through a disulfide bond is also described. ... International Institute Of Cancer Immunology Inc

Method for modifying t cell population

Provided is a method for increasing the proportion of memory t cells in a t cell population, said method comprising a step of adding a modulator for the retinoid metabolic pathway and/or a modulator for the retinoic acid signaling system to the t cell population.. . ... International Institute Of Cancer Immunology Inc

Immunotherapy for angiogenic disease

The present invention provides a pharmaceutical composition containing a cancer antigen peptide for treatment and prevention of angiogenic diseases.. . ... International Institute Of Cancer Immunology Inc

Cancer vaccine composition

A cancer vaccine composition for human leukocyte antigen (hla)-a*0206-positive persons, comprising a protein product of the tumor suppressor gene wt1 or a partial peptide thereof.. . ... International Institute Of Cancer Immunology Inc

Combination therapy with wt1 peptide vaccine and temozolomide

The present invention relates to combination therapy for cancer with a wt1 peptide vaccine and temozolomide.. . ... International Institute Of Cancer Immunology Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with International Institute Of Cancer Immunology Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for International Institute Of Cancer Immunology Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###